McKesson Corporation
| Formerly |
|
|---|---|
| Company type | Public |
| Industry | Healthcare |
| Founded | 1833 in New York City, U.S. |
| Founders |
|
| Headquarters | Irving, Texas , U.S. |
Key people |
|
| Products |
|
| Revenue | US$359 billion (2025) |
| US$4.42 billion (2025) | |
| US$3.29 billion (2025) | |
| Total assets | US$75.1 billion (2025) |
| Total equity | US$−2.1 billion (2025) |
Number of employees | c. 45,000 (2025) |
| Subsidiaries |
|
| Website | McKesson.com |
| Footnotes / references Financials as of March 31, 2025.[1] | |
McKesson Corporation is an American publicly traded company that distributes pharmaceuticals and provides health information technology, medical supplies, and health management tools. The company delivers a third of all pharmaceutical products used or consumed in North America and employs over 80,000 employees.[2][3] With $308.9 billion in 2024 revenue, it is the ninth-largest company by revenue in the United States and the nation's largest health care company. The company is headquartered in Irving, Texas. It is a component of the S&P 500 and is listed on the New York Stock Exchange, where it is traded under the ticker symbol "MCK".
McKesson provides extensive network of infrastructure for the healthcare industry and was an early adopter of technologies, including barcode scanning for distribution, pharmacy robotics, and RFID tags.[4] The company has been named in a federal lawsuit for profiting from the opioid epidemic in the United States.[5]
Throughout the COVID-19 pandemic, McKesson was a key vaccine distributor, serving as the United States of America Government's centralized distributor for hundreds of millions of COVID-19 vaccine doses and ancillary supply kits for over a billion doses across the United States.[6][7]
- ^ "FY 2025 Annual Report (Form 10-K)". U.S. Securities and Exchange Commission. May 9, 2025. pp. 9, 60, 62.
- ^ "McKesson | MCK Stock Price, Company Overview & News". Forbes. Retrieved 2025-01-15.
- ^ "Key Facts About McKesson | Health Care Services Leader | McKesson". www.mckesson.com. Retrieved 2025-01-15.
- ^ Mitchell, Luke (February 1, 2009). "Sick in the Head". Harper's Magazine. Archived from the original on May 25, 2017. Retrieved April 24, 2017.
- ^ Leggate, James (July 22, 2020). "What is McKesson?". FOXBusiness. Retrieved May 6, 2021.
- ^ Terry, Mark (17 August 2020). "Operation Warp Speed Selects McKesson for COVID-19 Vaccine Distribution". BioSpace. Retrieved 10 December 2021.
- ^ "McKESSON REPORTS FISCAL 2022 FOURTH-QUARTER AND FULL-YEAR RESULTS" (PDF). McKesson Investor Relations. Retrieved May 5, 2021.